MILANO VINCENT

Director at VERTICALNET INC · on record since Feb 16, 2006
Director at VIROPHARMA INC · on record since Jun 17, 2008
VP, Chief Financial Officer at VIROPHARMA INC · on record since Jul 24, 2003
Director at Vanda Pharmaceuticals Inc. · on record since Apr 22, 2010
Director at BIOCRYST PHARMACEUTICALS INC · on record since Jun 2, 2026
Director at Aclaris Therapeutics, Inc. · on record since Jun 8, 2026
Director at Aceragen, Inc. · on record since Dec 15, 2014
Director at Spark Therapeutics, Inc. · on record since Jan 29, 2015
PRESIDENT AND CEO at Aceragen, Inc. · on record since Mar 17, 2016

Insider trading activity of MILANO VINCENT

Transactions on record: 257; since Sep 8, 2003

Open-market buys: 23; $1.2M

Open-market sells: 12; $5.2M

Companies traded: 7; last filing Sep 2, 2026

Figures computed from official regulatory filings — .

Companies where MILANO VINCENT has traded

BIOCRYST PHARMACEUTICALS INC30 tx · $292.5K · Sep 2, 2026
Aclaris Therapeutics, Inc.24 tx · Jun 8, 2026
Aceragen, Inc.27 tx · $2.5M · Aug 11, 2023
Spark Therapeutics, Inc.14 tx · $343.5K · Dec 17, 2019
Vanda Pharmaceuticals Inc.12 tx · Jun 15, 2018
VIROPHARMA INC141 tx · $55.6M · Jan 28, 2014
9 tx · $3.7K · Jan 29, 2008

Track record of MILANO VINCENT

Statistical track record

Free

Open-market buys: 23

Last buy: May 20, 2024

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of MILANO VINCENT

Co-insiders of MILANO VINCENT

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 2, 2026	Award	1,159	9.70 USD	$11.2K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2026	AwardD (derivative)	33,540	0.00 USD	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2026	Award	15,294	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 8, 2026	AwardD (derivative)	10,987	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 8, 2026	ExerciseD (derivative)	-11,580	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 8, 2026	AwardD (derivative)	42,350	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 8, 2026	Exercise	11,580	—	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 2, 2026	Award	1,122	8.91 USD	$10K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 3, 2026	Award	848	8.75 USD	$7.4K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2025	Award	783	7.18 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 3, 2025	Award	676	8.31 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 16, 2025	AwardD (derivative)	27,181	0.00 USD	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 16, 2025	Award	12,500	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	42,350	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 9, 2025	ExerciseD (derivative)	-4,793	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 9, 2025	Exercise	4,793	—	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	11,580	0.00 USD	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 3, 2025	Award	523	10.75 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 4, 2025	Award	653	8.61 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2024	Award	750	7.50 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 3, 2024	Award	647	8.69 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 14, 2024	Award	6,820	0.00 USD	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 14, 2024	AwardD (derivative)	49,933	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	15,750	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	4,793	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 2, 2026	Award	1,159	9.70 USD	$11.2K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2026	AwardD (derivative)	33,540	0.00 USD	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2026	Award	15,294	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 8, 2026	AwardD (derivative)	10,987	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 8, 2026	ExerciseD (derivative)	-11,580	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 8, 2026	AwardD (derivative)	42,350	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 8, 2026	Exercise	11,580	—	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 2, 2026	Award	1,122	8.91 USD	$10K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 3, 2026	Award	848	8.75 USD	$7.4K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2025	Award	783	7.18 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 3, 2025	Award	676	8.31 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 16, 2025	AwardD (derivative)	27,181	0.00 USD	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 16, 2025	Award	12,500	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	42,350	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 9, 2025	ExerciseD (derivative)	-4,793	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 9, 2025	Exercise	4,793	—	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	11,580	0.00 USD	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 3, 2025	Award	523	10.75 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 4, 2025	Award	653	8.61 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2024	Award	750	7.50 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 3, 2024	Award	647	8.69 USD	$5.6K	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 14, 2024	Award	6,820	0.00 USD	—	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 14, 2024	AwardD (derivative)	49,933	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	15,750	0.00 USD	—	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	4,793	0.00 USD	—	SEC